1-6 of 6
Michael Voralia
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

A Randomized Trial Of Rituximab Vs Observation Following Autologous Stem Cell Transplantation (ASCT) For Relapsed Or Refractory CD20-Positive B Cell Lymphoma: Final Results Of NCIC CTG LY.12

Michael Crump, MD FRCPC, John Kuruvilla, MD, C. Tom Kouroukis, MD, MSc, FRCP(C), Ann Benger, MD, FRCP(C), Matthew C. Cheung, MD, FRCPC, Neil L Berinstein, MD, Stephen Couban, MD, FRCPC, Matthew D. Seftel, MBChB, FRCP(C), MRCP, Kang Howson-Jan, MD, Armand Keating, MD, Massimo Federico, MD, David A Macdonald, MD, FRCPC, Harold J. Olney, MD, Morel Rubinger, MD, Michael Voralia, A. Robert Turner, MD, FRCPC, Tara Baetz, MD, Annette E Hay, MBChB, Marina Djurfeldt, MSc, Ralph M. Meyer, MD, Bingshu Chen, PhD, Lois Shepherd, M.D.
Journal: Blood
Blood (2013) 122 (21): 155.
https://doi.org/10.1182/blood.V122.21.155.155
Published: 2013
Journal Articles

Gemcitabine, Dexamethasone, Cisplatin (GDP) Compared to Dexamethasone, Cytarabine, Cisplatin (DHAP) Chemotherapy Prior to Autologous Stem Cell Transplantation for Relapsed and Refractory Aggressive Lymphomas: Final Results of the Randomized Phase III NCIC CTG Study LY12

Michael Crump, MD, FRCPC, John Kuruvilla, MD, FRCPC, Stephen Couban, MD, FRCPC, David Macdonald, MD, FRCPC, Vishal Kukreti, MD, C. Tom Kouroukis, MD, MSc, FRCPC, Ralph M. Meyer, MD, Morel Rubinger, MD, Rena Buckstein, MD, Kevin R Imrie, MD, Massimo Federico, MD, Nicola Di Renzo, MD, Kang Howson-Jan, MD, Tara Baetz, MD, Leonard Kaizer, MD FRCPC, Michael Voralia, MD, FRCPC, Harold J. Olney, MD, A. Robert Turner, MD, FRCPC, Jonathan Sussman, MD, Annette E Hay, MBChB, Marina Djurfeldt, MSc, Bingshu E Chen, PhD, Lois Shepherd, MD
Journal: Blood
Blood (2012) 120 (21): 745.
https://doi.org/10.1182/blood.V120.21.745.745
Published: 2012
Journal Articles

Results from a Phase II Study of Lenalidomide Oral Monotherapy in Relapsed/Refractory Indolent Non-Hodgkin’s Lymphoma.

Thomas E. Witzig, MD, Julie M. Vose, MD, Timothy D. Moore, MD, Craig B. Reeder, MD, Craig E. Cole, MD, Glen Justice, MD, Henry P. Kaplan, MD, Michael Voralia, MD, Dennis Pietronigro, PhD, Kenichi Takeshita, MD, Annette Ervin-Haynes, DO, Jerome B. Zeldis, MD, PhD, Peter H. Wiernik, MD
Journal: Blood
Blood (2007) 110 (11): 2560.
https://doi.org/10.1182/blood.V110.11.2560.2560
Published: 2007
Journal Articles

Combination High-Dose Cyclophosphamide and Bortezomib Is Safe and Effective for Stem Cell Harvesting in Chemotherapy Refractory Multiple Myeloma.

Miriam Katzman, Theresa George, B.Sc., Heather Doell, B.Sc.N., Patricia Danyluk, B.Sc.P., Sheri Briggs, B.Sc.N., Wanda Hasegawa, M.D.,FRCPC, Christian Fibich, M.D., Michael Voralia, M.D.,FRCPC
Journal: Blood
Blood (2006) 108 (11): 5459.
https://doi.org/10.1182/blood.V108.11.5459.5459
Published: 2006
Journal Articles

A Prospective Phase II Comparison of Stem Cell Source Using Rituximab, Ifosfamide, Carboplatin, Etoposide (RICE) RE—Induction, Then High Dose Fludarabine, Busulfan (FLUBU) and Autologous (ASCT) or Allogeneic (AlloSCT) Hematopoietic Blood Stem Cell Transplantation for Mantle Cell (MCL) and Relapsed Low-Grade B-Cell Non-Hodgkin’s Lymphoma (NHL).

Douglas A. Stewart, MD, FRCPC, Michael Voralia, MD, FRCPC, Ahsan Chaudhry, MD, Oluyemi Jeje, MD, Donald Morris, MD, FRCPC, Lynn Savoie, MD, FRCPC, Chris Brown, MD, FRCPC, Wanda Hasagawa, MD, FRCPC, Nizar Bahlis, MD, James R. Russell, MB, BChir, FRCPC
Journal: Blood
Blood (2004) 104 (11): 915.
https://doi.org/10.1182/blood.V104.11.915.915
Published: 2004
Journal Articles

A molecular compendium of genes expressed in multiple myeloma

Jaime O. Claudio, Esther Masih-Khan, Hongchang Tang, Jason Gonçalves, Michael Voralia, Zhi Hua Li, Vincent Nadeem, Eva Cukerman, Ofelia Francisco-Pabalan, Choong Chin Liew, James R. Woodgett, A. Keith Stewart
Journal: Blood
Blood (2002) 100 (6): 2175–2186.
https://doi.org/10.1182/blood-2002-01-0008
Published: 2002